Amphastar Pharmaceuticals, Inc. (AMPH)
23.78
+0.24
(+1.02%)
USD |
NASDAQ |
Sep 11, 16:00
23.79
+0.01
(+0.04%)
After-Hours: 20:00
Amphastar Pharmaceuticals Market Cap : 1.011B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.011B |
| September 10, 2026 | 1.001B |
| September 09, 2026 | 979.94M |
| September 08, 2026 | 975.26M |
| September 04, 2026 | 985.90M |
| September 03, 2026 | 1.014B |
| September 02, 2026 | 1.010B |
| September 01, 2026 | 976.54M |
| August 31, 2026 | 958.25M |
| August 28, 2026 | 936.13M |
| August 27, 2026 | 930.60M |
| August 26, 2026 | 936.56M |
| August 25, 2026 | 934.86M |
| August 24, 2026 | 915.29M |
| August 21, 2026 | 918.70M |
| August 20, 2026 | 922.10M |
| August 19, 2026 | 924.65M |
| August 18, 2026 | 907.64M |
| August 17, 2026 | 887.22M |
| August 14, 2026 | 889.35M |
| August 13, 2026 | 858.30M |
| August 12, 2026 | 849.79M |
| August 11, 2026 | 868.51M |
| August 10, 2026 | 863.83M |
| August 07, 2026 | 883.82M |
| Date | Value |
|---|---|
| August 06, 2026 | 842.56M |
| August 05, 2026 | 860.85M |
| August 04, 2026 | 846.39M |
| August 03, 2026 | 902.56M |
| July 31, 2026 | 890.06M |
| July 30, 2026 | 909.70M |
| July 29, 2026 | 918.63M |
| July 28, 2026 | 899.43M |
| July 27, 2026 | 856.13M |
| July 24, 2026 | 835.60M |
| July 23, 2026 | 842.30M |
| July 22, 2026 | 861.49M |
| July 21, 2026 | 874.43M |
| July 20, 2026 | 876.22M |
| July 17, 2026 | 881.35M |
| July 16, 2026 | 886.49M |
| July 15, 2026 | 865.95M |
| July 14, 2026 | 839.40M |
| July 13, 2026 | 861.04M |
| July 10, 2026 | 835.60M |
| July 09, 2026 | 848.99M |
| July 08, 2026 | 842.74M |
| July 07, 2026 | 896.31M |
| July 06, 2026 | 875.33M |
| July 02, 2026 | 876.67M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Viatris, Inc. | 19.07B |
| Supernus Pharmaceuticals, Inc. | 2.422B |
| Liquidia Corp. | 5.947B |
| ANI Pharmaceuticals, Inc. | 1.612B |
| Corcept Therapeutics, Inc. | 12.17B |
Market Cap Related Metrics
| PE Ratio | 13.94 |
| PS Ratio | 1.511 |
| Price to Book Value | 1.317 |
| Price to Free Cash Flow | 7.214 |
| Price | 23.78 |
| Earnings Yield | 7.18% |
| Operating PE Ratio | 9.651 |
| Normalized PE Ratio | 15.74 |